Company / Net Debt per Share
Amgen Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$84.70
FY2025
5-year range
$43.78 / $100.50
FY2021-FY2025
Trend
-5.8%
vs FY2024
Sector context
#1 of 85
Health Care
What the data says
Among 85 Health Care companies, Amgen is in the bottom 1% for net debt per share. Net Debt per Share has fluctuated over the past 10 years, ranging from $37.36 in FY2018 to $100.50 in FY2023.
Based on SEC 10-K filings.
84.70 in FY2025 with a 5-year CAGR of +13.4%. Ranks 1st among 85 companies in Health Care.
Improved from $100.50 to $84.70 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +14.7%
- 5-Year CAGR
- +13.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 85This company $84.70 Sector average $1.18
▼
+7104.9% above sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 5.8% year-over-year.
- Ranks #1 out of 85 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2023.
- Lowest net debt per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $84.70 | -5.8% |
| FY2024 | $89.89 | -10.6% |
| FY2023 | $100.50 | +79.2% |
| FY2022 | $56.09 | +28.1% |
| FY2021 | $43.78 | -3.1% |
| FY2020 | $45.18 | +19.2% |
| FY2019 | $37.91 | +1.5% |
| FY2018 | $37.36 | -12.6% |
| FY2017 | $42.73 | +2.7% |
| FY2016 | $41.58 | +15.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026